Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03041467 · ClinicalTrials.gov registry record · NA
IN.PACT™ AV Access IDE Study
A NA study, sponsored by Medtronic Endovascular.
- Completed
- Registry status
- NA
- Development phase
- 330
- Enrollment target
NCT03041467 is a NA study that has completed, run by Medtronic Endovascular. The registered enrollment target is 330 participants.
The verdict
NCT03041467, a NA study, has completed, sponsored by Medtronic Endovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of the IN.PACT™ AV Access Drug Coated Balloon (DCB) compared to percutaneous transluminal angioplasty (PTA) for treatment of subjects presenting with de novo or non-stented restenotic obstructive lesion of native arteriovenous dialysis fistulae (AVF) in the upper extremity.
Interventions
- DEVICE IN.PACT AV DCB
- DEVICE Standard Balloon Angioplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2017-04-25 |
| Est. Completion | 2023-05-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03041467
The ClinicalTrials.gov registry entry for NCT03041467 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 330 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Endovascular, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IN.PACT AV DCB is the first listed.
NCT03041467 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03041467 about?
NCT03041467 is a clinical study titled "IN.PACT™ AV Access IDE Study". To evaluate the safety and efficacy of the IN.PACT™ AV Access Drug Coated Balloon (DCB) compared to percutaneous transluminal angioplasty (PTA) for treatment of subjects presenting with de novo or non-stented restenotic obstructive lesion of native arteriovenous dialysis fistulae (AVF) in the upper ...
What is the current status of trial NCT03041467?
This trial is currently completed. It is a NA study. The enrollment target is 330 participants. The study started on 2017-04-25. Estimated completion is 2023-05-05.
What interventions are being tested in trial NCT03041467?
The interventions under investigation include: IN.PACT AV DCB (DEVICE), Standard Balloon Angioplasty (DEVICE).
Who is sponsoring clinical trial NCT03041467?
This trial is sponsored by Medtronic Endovascular, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.